JPH09510235A - アレルギー性眼疾患を処置するためのドキセピン誘導体を含有する局所的眼科用処方物 - Google Patents
アレルギー性眼疾患を処置するためのドキセピン誘導体を含有する局所的眼科用処方物Info
- Publication number
- JPH09510235A JPH09510235A JP9500510A JP50051097A JPH09510235A JP H09510235 A JPH09510235 A JP H09510235A JP 9500510 A JP9500510 A JP 9500510A JP 50051097 A JP50051097 A JP 50051097A JP H09510235 A JPH09510235 A JP H09510235A
- Authority
- JP
- Japan
- Prior art keywords
- dimethylaminopropylidene
- acetic acid
- oxepin
- dihydrodibenz
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.アレルギー性眼疾患を処置するための方法であって、治療的有効量の11-( 3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b,e]オキセピン-2-酢 酸またはその薬学的に受容可能な塩を含有する組成物を眼に局所的に投与する工 程を包含する、方法。 2.前記組成物が溶液であり、前記11-(3-ジメチルアミノプロピリデン)-6,11 -ジヒドロジベンズ[b,e]オキセピン-2-酢酸の量が、約0.0001 w/v%から約5% (w/v)である、請求項1に記載の方法。 3.前記11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b,e]オ キセピン-2-酢酸の量が、約0.001から約0.2%(w/v)である、請求項2に記載の 方法。 4.前記11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b,e]オ キセピン-2-酢酸の量が、約0.1%(w/v)である、請求項3に記載の方法。 5.前記11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b,e]オ キセピン-2-酢酸が、(Z)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジ ベンズ[b,e]オキセピン-2-酢酸であり、(E)-11-(3-ジメチルアミノプロピリデン )-6,11-ジヒドロジベンズ[b,e]オキセピン-2-酢酸を実質的に含まない、請求項 1に記載の方法。 6.前記(Z)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b, e]オキセピン-2-酢酸の量が、約0.0001から約5%(w/v)である、請求項5に記 載の方法。 7.前記(Z)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b, e]オキセピン-2-酢酸の量が、約0.001から約0.2%(w/v)である、請求項6に記 載の方法。 8.前記(Z)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b, e]オキセピン-2-酢酸の量が、0.1%(w/v)である、請求項7に記載の方法。 9.前記11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b,e]オ キセピン-2-酢酸が、(E)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジ ベンズ[b,e]オキセピン-2-酢酸であり、(Z)-11-(3-ジメチルアミノプロピリデン )-6,11-ジヒドロジベンズ[b,e]オキセピン-2-酢酸を実質的に含まない、請求項 1に記載の方法。 10.前記(E)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[ b,e]オキセピン-2-酢酸の量が、約0.0001から約5%(w/v)である、請求項9に 記載の方法。 11.前記(E)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[ b,e]オキセピン-2-酢酸の量が、約0.001から約0.2%(w/v)である、請求項10 に記載の方法。 12.前記(E)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[ b,e]オキセピン-2-酢酸の量が、約0.1%(w/v)である、請求項11に記載の方 法。 13.アレルギー性眼疾患を処置するための局所投与可能な眼科用組成物であ って、治療的有効量の11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベ ンズ[b,e]オキセピン-2-酢酸またはその薬学的に受容可能な塩を含有する、組成 物。 14.前記11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b,e] オキセピン-2-酢酸の量が、約0.0001から約5%(w/v)である、請求項13に記 載の組成物。 15.前記11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b,e] オキセピン-2-酢酸の量が、約0.001から約0.2%(w/v)である、請求項14に記 載の組成物。 16.前記11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b,e] オキセピン-2-酢酸の量が、約0.1%(w/v)である、請求項15に記載の組成物 。 17.前記11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b,e] オキセピン-2-酢酸が、(Z)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロ ジベンズ[b,e]オキセピン-2-酢酸であり、(E)-11-(3-ジメチルアミノプロピリデ ン)-6,11-ジヒドロジベンズ[b,e]オキセピン-2-酢酸を実質的に含まない、請求 項13に記載の組成物。 18.前記(Z)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[ b,e]オキセピン-2-酢酸の量が、約0.0001から約5%(w/v)である、請求項17 に記載の組成物。 19.前記(Z)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[ b,e]オキセピン-2-酢酸の量が、約0.001から約0.2%(w/v)である、請求項18 に記載の組成物。 20.前記(Z)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[ b,e]オキセピン-2-酢酸の量が、約0.1%(w/v)である、請求項19に記載の組 成物。 21.前記11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[b,e] オキセピン-2-酢酸が、(E)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロ ジベンズ[b,e]オキセピン-2-酢酸であり、(Z)-11-(3-ジメチルアミノプロピリデ ン)-6,11-ジヒドロジベンズ[b,e]オキセピン-2-酢酸を実質的に含まない、請求 項13に記載の組成物。 22.前記(E)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[ b,e]オキセピン-2-酢酸の量が、約0.0001から約5%(w/v)である、請求項21 に記載の組成物。 23.前記(E)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[ b,e]オキセピン-2-酢酸の量が、約0.001から約0.2%(w/v)である、請求項22 に記載の組成物。 24.前記(E)-11-(3-ジメチルアミノプロピリデン)-6,11-ジヒドロジベンズ[ b,e]オキセピン-2-酢酸の量が、約0.1%(w/v)である、請求項23に記載の組 成物。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/469,729 | 1995-06-06 | ||
US08/469,729 US5641805A (en) | 1995-06-06 | 1995-06-06 | Topical ophthalmic formulations for treating allergic eye diseases |
US469,729 | 1995-06-06 | ||
PCT/US1996/006289 WO1996039147A2 (en) | 1995-06-06 | 1996-05-03 | Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH09510235A true JPH09510235A (ja) | 1997-10-14 |
JP3068858B2 JP3068858B2 (ja) | 2000-07-24 |
Family
ID=23864859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9500510A Expired - Lifetime JP3068858B2 (ja) | 1995-06-06 | 1996-05-03 | アレルギー性眼疾患を処置するためのドキセピン誘導体を含有する局所的眼科用処方物 |
Country Status (20)
Country | Link |
---|---|
US (1) | US5641805A (ja) |
EP (1) | EP0799044B1 (ja) |
JP (1) | JP3068858B2 (ja) |
KR (1) | KR100202155B1 (ja) |
CN (1) | CN1082367C (ja) |
AT (1) | ATE220906T1 (ja) |
AU (1) | AU698854B2 (ja) |
CA (1) | CA2195094C (ja) |
DE (2) | DE10299034I2 (ja) |
DK (1) | DK0799044T3 (ja) |
ES (1) | ES2179198T3 (ja) |
FI (1) | FI970489A0 (ja) |
LU (1) | LU90969I2 (ja) |
MX (1) | MX9701013A (ja) |
MY (1) | MY116651A (ja) |
NL (1) | NL300101I2 (ja) |
NO (1) | NO311637B1 (ja) |
PT (1) | PT799044E (ja) |
TW (1) | TW438588B (ja) |
WO (1) | WO1996039147A2 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002520355A (ja) * | 1998-07-14 | 2002-07-09 | アルコン ラボラトリーズ, インコーポレイテッド | 非アレルギー性眼炎症障害を処置および眼新生血管形成を予防する医薬製造のための、11−(3−ジメチルアミノプロピリデン)−6,11−ジヒドロジベンズ[b,e]オキセピン−2−酢酸の使用 |
WO2009031682A1 (ja) | 2007-09-06 | 2009-03-12 | Kyowa Hakko Kirin Co., Ltd. | ジベンゾ[b,e]オキセピン誘導体含有点眼剤 |
JP2013506692A (ja) * | 2009-10-01 | 2013-02-28 | アルコン リサーチ, リミテッド | オロパタジン組成物およびその使用 |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5859000A (en) * | 1995-06-07 | 1999-01-12 | University Of Utah Research Foundation | Method for reducing mast cell mediated allergic reactions |
US6174914B1 (en) | 1999-06-15 | 2001-01-16 | Alcon Laboratories, Inc. | Method of inhibiting cytokine release from human ocular cells |
DE60008730T2 (de) | 1999-06-18 | 2004-08-05 | Alcon Manufacturing Ltd., Fort Worth | Methode zur konzentrationsbestimmung einer amphipathischen antihistaminischen verbindung durch bestimmung ihrer oberflächen aktivitäts einstufung |
JP2003520813A (ja) | 2000-01-25 | 2003-07-08 | アルコン,インコーポレイテッド | コンタクトレンズでの使用に適する眼の抗アレルギー組成物 |
JP2003534318A (ja) | 2000-05-19 | 2003-11-18 | アルコン,インコーポレイテッド | アレルギー性疾患を処置するために有用なジスルフィド誘導体 |
CN1173697C (zh) | 2000-05-19 | 2004-11-03 | 爱尔康公司 | 用于治疗过敏性疾病的苯胺二硫化物衍生物 |
EP1284722B1 (en) | 2000-05-19 | 2005-08-24 | Alcon Inc. | Compositions containing a benzamide disulfide derivative for treating allergic diseases |
EP1387696A2 (en) * | 2001-05-03 | 2004-02-11 | Novartis AG | Anti-ige antibody to treat ocular allergies |
US7977376B2 (en) | 2001-06-27 | 2011-07-12 | Novartis Ag | Olopatadine formulations for topical nasal administration |
TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
MXPA04005417A (es) * | 2001-12-05 | 2004-10-11 | Alcon Inc | Uso de antagonista de h1 y un esteroide seguro para el tratamiento de la rinitis. |
US20050209312A1 (en) * | 2004-03-19 | 2005-09-22 | Bausch & Lomb Incorporated | Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative |
AU2005259911A1 (en) * | 2004-06-28 | 2006-01-12 | Alcon, Inc. | Topical formulations for treating allergic diseases |
ZA200704139B (en) * | 2004-11-24 | 2008-10-29 | Alcon Inc | Method of delivering nasal spray |
KR20080038335A (ko) * | 2005-07-08 | 2008-05-06 | 센주 세이야꾸 가부시키가이샤 | 올로파타딘을 포함하는 경피 흡수 안과 제제 |
CA2648115C (en) | 2006-03-31 | 2015-03-24 | Vistakon Pharmaceuticals, Llc | Ocular allergy treatments |
US20080139531A1 (en) * | 2006-12-04 | 2008-06-12 | Alcon Manufacturing Ltd. | Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair |
HUE026162T2 (en) | 2007-02-07 | 2016-05-30 | Novartis Ag | Olopatadine preparation for topical nasal administration |
US20090182035A1 (en) * | 2007-04-11 | 2009-07-16 | Alcon Research, Ltd. | Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |
KR20100014565A (ko) * | 2007-04-11 | 2010-02-10 | 알콘 리서치, 리미티드 | 알레르기성 비염 및 알레르기성 결막염을 치료하기 위한 tnfa의 억제제 및 항히스타민의 용도 |
US10517839B2 (en) * | 2008-06-09 | 2019-12-31 | Cornell University | Mast cell inhibition in diseases of the retina and vitreous |
IT1397503B1 (it) | 2009-04-21 | 2013-01-16 | F S I Fabbrica Italiana Sint | Processo per la preparazione di olopatadina |
ES2432502T3 (es) * | 2009-07-17 | 2013-12-03 | Alcon Research, Ltd. | Pauta terapéutica de pulverización nasal de olopatadina para niños |
WO2011027322A1 (en) | 2009-09-03 | 2011-03-10 | Ranbaxy Laboratories Limited | Extended release dosage form containing olopatadine for oral administration |
TW201206936A (en) | 2010-07-19 | 2012-02-16 | Alcon Res Ltd | Methods and compositions for the treatment of allergy |
TWI544922B (zh) * | 2011-05-19 | 2016-08-11 | 愛爾康研究有限公司 | 高濃度歐羅派特錠(olopatadine)眼用組成物 |
CN103202833A (zh) * | 2012-12-25 | 2013-07-17 | 常州市亚邦医药研究所有限公司 | 一种奥洛他定或其盐的药用组合物及其制备方法 |
US20160271097A1 (en) * | 2013-10-31 | 2016-09-22 | Nephron Pharmaceuticals Corporation | Formulation of olopatadine |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4370324A (en) * | 1980-09-17 | 1983-01-25 | Bernstein Joel E | Method and composition for treating and preventing irritation of the eyes |
GB8520662D0 (en) * | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
US4923892A (en) * | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
JPS6310784A (ja) * | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
-
1995
- 1995-06-06 US US08/469,729 patent/US5641805A/en not_active Expired - Lifetime
-
1996
- 1996-05-03 AT AT96915500T patent/ATE220906T1/de active
- 1996-05-03 EP EP96915500A patent/EP0799044B1/en not_active Expired - Lifetime
- 1996-05-03 PT PT96915500T patent/PT799044E/pt unknown
- 1996-05-03 KR KR1019970700721A patent/KR100202155B1/ko active IP Right Review Request
- 1996-05-03 CA CA002195094A patent/CA2195094C/en not_active Expired - Lifetime
- 1996-05-03 WO PCT/US1996/006289 patent/WO1996039147A2/en active IP Right Grant
- 1996-05-03 DK DK96915500T patent/DK0799044T3/da active
- 1996-05-03 MX MX9701013A patent/MX9701013A/es unknown
- 1996-05-03 DE DE2002199034 patent/DE10299034I2/de active Active
- 1996-05-03 DE DE69622527T patent/DE69622527T2/de not_active Expired - Lifetime
- 1996-05-03 AU AU57261/96A patent/AU698854B2/en not_active Expired
- 1996-05-03 CN CN96190605A patent/CN1082367C/zh not_active Ceased
- 1996-05-03 ES ES96915500T patent/ES2179198T3/es not_active Expired - Lifetime
- 1996-05-03 JP JP9500510A patent/JP3068858B2/ja not_active Expired - Lifetime
- 1996-05-14 MY MYPI96001818A patent/MY116651A/en unknown
- 1996-06-04 TW TW085106668A patent/TW438588B/zh not_active IP Right Cessation
-
1997
- 1997-02-05 NO NO19970517A patent/NO311637B1/no not_active IP Right Cessation
- 1997-02-05 FI FI970489A patent/FI970489A0/fi unknown
-
2002
- 2002-09-19 NL NL300101C patent/NL300101I2/nl unknown
- 2002-10-02 LU LU90969C patent/LU90969I2/fr unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002520355A (ja) * | 1998-07-14 | 2002-07-09 | アルコン ラボラトリーズ, インコーポレイテッド | 非アレルギー性眼炎症障害を処置および眼新生血管形成を予防する医薬製造のための、11−(3−ジメチルアミノプロピリデン)−6,11−ジヒドロジベンズ[b,e]オキセピン−2−酢酸の使用 |
WO2009031682A1 (ja) | 2007-09-06 | 2009-03-12 | Kyowa Hakko Kirin Co., Ltd. | ジベンゾ[b,e]オキセピン誘導体含有点眼剤 |
JP5307015B2 (ja) * | 2007-09-06 | 2013-10-02 | 協和発酵キリン株式会社 | ジベンゾ[b,e]オキセピン誘導体含有点眼剤 |
JP2013506692A (ja) * | 2009-10-01 | 2013-02-28 | アルコン リサーチ, リミテッド | オロパタジン組成物およびその使用 |
Also Published As
Publication number | Publication date |
---|---|
DK0799044T3 (da) | 2002-10-14 |
FI970489A (fi) | 1997-02-05 |
AU698854B2 (en) | 1998-11-12 |
EP0799044B1 (en) | 2002-07-24 |
KR100202155B1 (ko) | 1999-06-15 |
NO970517D0 (no) | 1997-02-05 |
DE10299034I1 (de) | 2003-01-23 |
CN1161000A (zh) | 1997-10-01 |
ATE220906T1 (de) | 2002-08-15 |
KR970704452A (ko) | 1997-09-06 |
PT799044E (pt) | 2002-11-29 |
FI970489A0 (fi) | 1997-02-05 |
NO970517L (no) | 1997-04-03 |
DE69622527D1 (de) | 2002-08-29 |
NL300101I2 (nl) | 2003-01-06 |
DE10299034I2 (de) | 2005-07-07 |
MX9701013A (es) | 1997-05-31 |
NL300101I1 (nl) | 2002-12-02 |
CA2195094A1 (en) | 1996-12-12 |
WO1996039147A3 (en) | 1997-02-20 |
EP0799044A2 (en) | 1997-10-08 |
AU5726196A (en) | 1996-12-24 |
NO311637B1 (no) | 2001-12-27 |
JP3068858B2 (ja) | 2000-07-24 |
LU90969I2 (fr) | 2002-12-02 |
CN1082367C (zh) | 2002-04-10 |
TW438588B (en) | 2001-06-07 |
MY116651A (en) | 2004-03-31 |
US5641805A (en) | 1997-06-24 |
CA2195094C (en) | 2002-02-26 |
DE69622527T2 (de) | 2002-12-05 |
WO1996039147A2 (en) | 1996-12-12 |
ES2179198T3 (es) | 2003-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH09510235A (ja) | アレルギー性眼疾患を処置するためのドキセピン誘導体を含有する局所的眼科用処方物 | |
Yanni et al. | The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent | |
US4599353A (en) | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma | |
TWI578990B (zh) | 眼睛過敏之治療 | |
US20050228054A1 (en) | Methods for treating eye disorders | |
JP5738292B2 (ja) | Jak経路の阻害のための組成物および方法 | |
US20080305994A1 (en) | Pharmaceutical Compositions and Method for Treating, Reducing, Ameliorating, Alleviating, or Preventing Dry Eye | |
JPH0725679B2 (ja) | 眼圧制御剤 | |
EP1928444A2 (en) | Use of ambroxol for the treatment of rhinovirus infections | |
WOODWARD et al. | The pruritogenic and inflammatory effects of prostanoids in the conjunctiva | |
Discepola et al. | Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis | |
HUT70749A (en) | Anti-allergic pharmaceutical composition containing suplatast-tosilate for ophthalmic topical administracion and process for producing them | |
JP2746832B2 (ja) | 眼局所抗アレルギー剤 | |
US5266580A (en) | Treatment of low pressure glaucoma and ischemic retinal degeneration with droperidol | |
WO2022165415A1 (en) | Use of proteasome inhibitors in the treatment of coronavirus infections | |
EA029157B1 (ru) | Терапия макулярной дегенерации на основе баклофена и акампросата | |
US5252568A (en) | Treatment of low pressure glaucoma and ischemic retinal degeneration with loxapine | |
US6916845B2 (en) | Method for prevention and treatment of male and female sexual dysfunction | |
Leopold | Advances in Ocular Therapy: Noncorticosteroid Anti-Inflammatory Agents: Fifth Annual Jules Stein Lecture | |
JP2001072591A (ja) | 網膜神経細胞保護剤 | |
JPH10203982A (ja) | 視機能障害の予防・治療剤 | |
RU2184544C1 (ru) | Противоаллергический препарат | |
WO2024010765A1 (en) | Compositions for treating 5-ht2 conditions and methods of using the same | |
CA3213205A1 (en) | Use of mebendazole for treating viral infection | |
Morlet et al. | Etoposide as a virocidal anticytomegalovirus therapy: intravitreal toxicology and pharmacology in rabbits |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
R150 | Certificate of patent or registration of utility model |
Ref document number: 3068858 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050104 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20050523 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050628 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S202 | Request for registration of non-exclusive licence |
Free format text: JAPANESE INTERMEDIATE CODE: R315201 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080519 Year of fee payment: 8 |
|
R153 | Grant of patent term extension |
Free format text: JAPANESE INTERMEDIATE CODE: R153 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080519 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090519 Year of fee payment: 9 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090519 Year of fee payment: 9 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090519 Year of fee payment: 9 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090519 Year of fee payment: 9 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090519 Year of fee payment: 9 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090519 Year of fee payment: 9 |
|
R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100519 Year of fee payment: 10 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110519 Year of fee payment: 11 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110519 Year of fee payment: 11 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110519 Year of fee payment: 11 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110519 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120519 Year of fee payment: 12 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130519 Year of fee payment: 13 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130519 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130519 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130519 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130519 Year of fee payment: 13 |
|
R157 | Certificate of patent or utility model (correction) |
Free format text: JAPANESE INTERMEDIATE CODE: R157 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130519 Year of fee payment: 13 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R157 | Certificate of patent or utility model (correction) |
Free format text: JAPANESE INTERMEDIATE CODE: R157 |
|
EXPY | Cancellation because of completion of term |